Journal Article
. 2019 Aug; 116(34):16971-16980.
doi: 10.1073/pnas.1905005116.

Immuno-PET identifies the myeloid compartment as a key contributor to the outcome of the antitumor response under PD-1 blockade

Mohammad Rashidian 1 Martin W LaFleur 2 Vincent L Verschoor 1 Anushka Dongre 3 Yun Zhang 3 Thao H Nguyen 2 Stephen Kolifrath 1 Amir R Aref 4 Christie J Lau 4 Cloud P Paweletz 4 Xia Bu 4 Gordon J Freeman 4 M Inmaculada Barrasa 3 Robert A Weinberg 3 Arlene H Sharpe 2 Hidde L Ploegh 5 
Affiliations
  • PMID: 31375632
  •     45 References
  •     45 citations

Abstract

Immunotherapy using checkpoint-blocking antibodies against PD-1 has produced impressive results in a wide range of cancers. However, the response remains heterogeneous among patients. We used noninvasive immuno-positron emission tomography (PET), using 89Zr-labeled PEGylated single-domain antibody fragments (nanobodies or VHHs), to explore the dynamics and distribution of intratumoral CD8+ T cells and CD11b+ myeloid cells in response to anti-PD-1 treatment in the MC38 colorectal mouse adenocarcinoma model. Responding and nonresponding tumors showed consistent differences in the distribution of CD8+ and CD11b+ cells. Anti-PD-1 treatment mobilized CD8+ T cells from the tumor periphery to a more central location. Only those tumors fully infiltrated by CD8+ T cells went on to complete resolution. All tumors contained CD11b+ myeloid cells from the outset of treatment, with later recruitment of additional CD11b+ cells. As tumors grew, the distribution of intratumoral CD11b+ cells became more heterogeneous. Shrinkage of tumors in responders correlated with an increase in the CD11b+ population in the center of the tumors. The changes in distribution of CD8+ and CD11b+ cells, as assessed by PET, served as biomarkers to gauge the efficacy of anti-PD-1 treatment. Single-cell RNA sequencing of RNA from intratumoral CD45+ cells showed that CD11b+ cells in responders and nonresponders were markedly different. The responders exhibited a dominant population of macrophages with an M1-like signature, while the CD45+ population in the nonresponders displayed an M2-like transcriptional signature. Thus, by using immuno-PET and single-cell RNA sequencing, we show that anti-PD-1 treatment not only affects interactions of CD8+ T cells with the tumor but also impacts the intratumoral myeloid compartment.

Keywords: PET imaging; checkpoint blockade; nanobodies; single-cell RNA sequencing; tumor immune microenvironment.

Alternatively activated macrophages differentially express fibronectin and its splice variants and the extracellular matrix protein betaIG-H3.
A Gratchev, P Guillot, +4 authors, S Goerdt.
Scand J Immunol, 2001 Apr 04; 53(4). PMID: 11285119
CC chemokine ligand 3 (CCL3) regulates CD8(+)-T-cell effector function and migration following viral infection.
Matthew J Trifilo, Cornelia C Bergmann, William A Kuziel, Thomas E Lane.
J Virol, 2003 Mar 14; 77(7). PMID: 12634360    Free PMC article.
Genomic segmental polymorphisms in inbred mouse strains.
Jiangzhen Li, Tao Jiang, +7 authors, Wei-Wen Cai.
Nat Genet, 2004 Aug 24; 36(9). PMID: 15322544
The S1P-analog FTY720 differentially modulates T-cell homing via HEV: T-cell-expressed S1P1 amplifies integrin activation in peripheral lymph nodes but not in Peyer patches.
Cornelia Halin, M Lucila Scimone, +6 authors, Ulrich H von Andrian.
Blood, 2005 May 05; 106(4). PMID: 15870184    Free PMC article.
CD11b+/Gr-1+ immature myeloid cells mediate suppression of T cells in mice bearing tumors of IL-1beta-secreting cells.
Xiaoping Song, Yakov Krelin, +5 authors, Ron N Apte.
J Immunol, 2005 Dec 13; 175(12). PMID: 16339559
Highly Cited.
Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer.
Eiichi Sato, Sara H Olson, +15 authors, Kunle Odunsi.
Proc Natl Acad Sci U S A, 2005 Dec 14; 102(51). PMID: 16344461    Free PMC article.
Highly Cited.
PD-1 and its ligands in T-cell immunity.
Mary E Keir, Loise M Francisco, Arlene H Sharpe.
Curr Opin Immunol, 2007 Apr 17; 19(3). PMID: 17433872
Highly Cited. Review.
The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages.
Paola Allavena, Antonio Sica, +2 authors, Alberto Mantovani.
Crit Rev Oncol Hematol, 2007 Oct 05; 66(1). PMID: 17913510
Highly Cited. Review.
Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer.
Osamu Kawai, Genichiro Ishii, +9 authors, Atsushi Ochiai.
Cancer, 2008 Aug 02; 113(6). PMID: 18671239
Highly Cited.
Myeloid-derived suppressor cells: linking inflammation and cancer.
Suzanne Ostrand-Rosenberg, Pratima Sinha.
J Immunol, 2009 Apr 04; 182(8). PMID: 19342621    Free PMC article.
Highly Cited. Review.
Conjugation and radiolabeling of monoclonal antibodies with zirconium-89 for PET imaging using the bifunctional chelate p-isothiocyanatobenzyl-desferrioxamine.
Maria J W D Vosjan, Lars R Perk, +4 authors, Guus A M S van Dongen.
Nat Protoc, 2010 Apr 03; 5(4). PMID: 20360768
Highly Cited.
CD8+ tumor-infiltrating lymphocytes predict favorable prognosis in malignant pleural mesothelioma after resection.
Noriyuki Yamada, Satoshi Oizumi, +8 authors, Masaharu Nishimura.
Cancer Immunol Immunother, 2010 Jun 23; 59(10). PMID: 20567822
Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in mice.
Tangying Lu, Rupal Ramakrishnan, +7 authors, Dmitry Gabrilovich.
J Clin Invest, 2011 Sep 14; 121(10). PMID: 21911941    Free PMC article.
Highly Cited.
Immune inhibitory molecules LAG-3 and PD-1 synergistically regulate T-cell function to promote tumoral immune escape.
Seng-Ryong Woo, Meghan E Turnis, +18 authors, Dario A A Vignali.
Cancer Res, 2011 Dec 22; 72(4). PMID: 22186141    Free PMC article.
Highly Cited.
Accessories to the crime: functions of cells recruited to the tumor microenvironment.
Douglas Hanahan, Lisa M Coussens.
Cancer Cell, 2012 Mar 24; 21(3). PMID: 22439926
Highly Cited. Review.
STAR: ultrafast universal RNA-seq aligner.
Alexander Dobin, Carrie A Davis, +6 authors, Thomas R Gingeras.
Bioinformatics, 2012 Oct 30; 29(1). PMID: 23104886    Free PMC article.
Highly Cited.
Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma.
Tyler R Simpson, Fubin Li, +11 authors, Sergio A Quezada.
J Exp Med, 2013 Jul 31; 210(9). PMID: 23897981    Free PMC article.
Highly Cited.
Beneficial impact of CCL2 and CCL12 neutralization on experimental malignant pleural effusion.
Antonia Marazioti, Chrysoula A Kairi, +8 authors, Georgios T Stathopoulos.
PLoS One, 2013 Aug 24; 8(8). PMID: 23967166    Free PMC article.
featureCounts: an efficient general purpose program for assigning sequence reads to genomic features.
Yang Liao, Gordon K Smyth, Wei Shi.
Bioinformatics, 2013 Nov 15; 30(7). PMID: 24227677
Highly Cited.
The M1 and M2 paradigm of macrophage activation: time for reassessment.
Fernando O Martinez, Siamon Gordon.
F1000Prime Rep, 2014 Mar 29; 6. PMID: 24669294    Free PMC article.
Highly Cited. Review.
Mechanism of tumor rejection with doublets of CTLA-4, PD-1/PD-L1, or IDO blockade involves restored IL-2 production and proliferation of CD8(+) T cells directly within the tumor microenvironment.
Stefani Spranger, Holly K Koblish, +3 authors, Thomas F Gajewski.
J Immunother Cancer, 2014 May 16; 2. PMID: 24829760    Free PMC article.
Highly Cited.
Tumor-associated macrophages: from mechanisms to therapy.
Roy Noy, Jeffrey W Pollard.
Immunity, 2014 Jul 19; 41(1). PMID: 25035953    Free PMC article.
Highly Cited. Review.
PD-1 blockade induces responses by inhibiting adaptive immune resistance.
Paul C Tumeh, Christina L Harview, +23 authors, Antoni Ribas.
Nature, 2014 Nov 28; 515(7528). PMID: 25428505    Free PMC article.
Highly Cited.
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2.
Michael I Love, Wolfgang Huber, Simon Anders.
Genome Biol, 2014 Dec 18; 15(12). PMID: 25516281    Free PMC article.
Highly Cited.
T cell exclusion, immune privilege, and the tumor microenvironment.
Johanna A Joyce, Douglas T Fearon.
Science, 2015 Apr 04; 348(6230). PMID: 25838376
Highly Cited. Review.
Noninvasive imaging of immune responses.
Mohammad Rashidian, Edmund J Keliher, +8 authors, Hidde L Ploegh.
Proc Natl Acad Sci U S A, 2015 Apr 23; 112(19). PMID: 25902531    Free PMC article.
Highly Cited.
An Effective Immuno-PET Imaging Method to Monitor CD8-Dependent Responses to Immunotherapy.
Richard Tavaré, Helena Escuin-Ordinas, +6 authors, Anna M Wu.
Cancer Res, 2015 Nov 18; 76(1). PMID: 26573799    Free PMC article.
Highly Cited.
Enzyme-Mediated Modification of Single-Domain Antibodies for Imaging Modalities with Different Characteristics.
Mohammad Rashidian, Lu Wang, +7 authors, Steven H Liang.
Angew Chem Int Ed Engl, 2015 Dec 03; 55(2). PMID: 26630549    Free PMC article.
Coinhibitory Pathways in Immunotherapy for Cancer.
Susanne H Baumeister, Gordon J Freeman, Glenn Dranoff, Arlene H Sharpe.
Annu Rev Immunol, 2016 Mar 02; 34. PMID: 26927206
Highly Cited. Review.
The use of 18F-2-fluorodeoxyglucose (FDG) to label antibody fragments for immuno-PET of pancreatic cancer.
Mohammad Rashidian, Edmund Keliher, +9 authors, Hidde Ploegh.
ACS Cent Sci, 2016 Mar 10; 1(3). PMID: 26955657    Free PMC article.
Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy.
Se Jin Im, Masao Hashimoto, +13 authors, Rafi Ahmed.
Nature, 2016 Aug 09; 537(7620). PMID: 27501248    Free PMC article.
Highly Cited.
Guanylate-binding protein 5 is a marker of interferon-γ-induced classically activated macrophages.
Yukio Fujiwara, Yoshiyuki Hizukuri, +5 authors, Yasuhiro Hayashi.
Clin Transl Immunology, 2016 Dec 19; 5(11). PMID: 27990286    Free PMC article.
Reinvigorating Exhausted T Cells by Blockade of the PD-1 Pathway.
Junghwa Lee, Eunseon Ahn, Haydn T Kissick, Rafi Ahmed.
For Immunopathol Dis Therap, 2015 Jan 01; 6(1-2). PMID: 28286692    Free PMC article.
Epithelial-to-Mesenchymal Transition Contributes to Immunosuppression in Breast Carcinomas.
Anushka Dongre, Mohammad Rashidian, +4 authors, Robert A Weinberg.
Cancer Res, 2017 Apr 22; 77(15). PMID: 28428275    Free PMC article.
Highly Cited.
New insights into the role of EMT in tumor immune escape.
Stéphane Terry, Pierre Savagner, +4 authors, Salem Chouaib.
Mol Oncol, 2017 Jun 15; 11(7). PMID: 28614624    Free PMC article.
Highly Cited. Review.
Predicting the response to CTLA-4 blockade by longitudinal noninvasive monitoring of CD8 T cells.
Mohammad Rashidian, Jessica R Ingram, +11 authors, Hidde L Ploegh.
J Exp Med, 2017 Jul 02; 214(8). PMID: 28666979    Free PMC article.
Highly Cited.
Upregulation of PD-L1 by SPP1 mediates macrophage polarization and facilitates immune escape in lung adenocarcinoma.
Yan Zhang, Weiwei Du, Zhaoliang Chen, Cheng Xiang.
Exp Cell Res, 2017 Aug 24; 359(2). PMID: 28830685
Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids.
Russell W Jenkins, Amir R Aref, +81 authors, David A Barbie.
Cancer Discov, 2017 Nov 05; 8(2). PMID: 29101162    Free PMC article.
Highly Cited.
SNAIL1 action in tumor cells influences macrophage polarization and metastasis in breast cancer through altered GM-CSF secretion.
Audrey Brenot, Brett L Knolhoff, David G DeNardo, Gregory D Longmore.
Oncogenesis, 2018 Mar 30; 7(3). PMID: 29593211    Free PMC article.
Integrating single-cell transcriptomic data across different conditions, technologies, and species.
Andrew Butler, Paul Hoffman, +2 authors, Rahul Satija.
Nat Biotechnol, 2018 Apr 03; 36(5). PMID: 29608179    Free PMC article.
Highly Cited.
Macrophages: The Road Less Traveled, Changing Anticancer Therapy.
Jennifer L Guerriero.
Trends Mol Med, 2018 Apr 16; 24(5). PMID: 29655673    Free PMC article.
Highly Cited. Review.
3D microfluidic ex vivo culture of organotypic tumor spheroids to model immune checkpoint blockade.
Amir R Aref, Marco Campisi, +20 authors, Russell W Jenkins.
Lab Chip, 2018 Sep 06; 18(20). PMID: 30183789    Free PMC article.
High-Dimensional Analysis Delineates Myeloid and Lymphoid Compartment Remodeling during Successful Immune-Checkpoint Cancer Therapy.
Matthew M Gubin, Ekaterina Esaulova, +16 authors, Maxim N Artyomov.
Cell, 2018 Oct 23; 175(4). PMID: 30343900    Free PMC article.
Highly Cited.
T-cell antigen receptor genes and T-cell recognition.
M M Davis, P J Bjorkman.
Nature, 1988 Aug 04; 334(6181). PMID: 3043226
Highly Cited. Review.
The human T cell antigen receptor is encoded by variable, diversity, and joining gene segments that rearrange to generate a complete V gene.
G Siu, S P Clark, +5 authors, L Hood.
Cell, 1984 Jun 01; 37(2). PMID: 6202421
Highly Cited.
Targeting STAT3 and STAT5 in Tumor-Associated Immune Cells to Improve Immunotherapy.
Grégory Verdeil, Toby Lawrence, Anne-Marie Schmitt-Verhulst, Nathalie Auphan-Anezin.
Cancers (Basel), 2019 Nov 27; 11(12). PMID: 31766350    Free PMC article.
Review.
Current Strategies to Target Tumor-Associated-Macrophages to Improve Anti-Tumor Immune Responses.
Clément Anfray, Aldo Ummarino, Fernando Torres Andón, Paola Allavena.
Cells, 2019 Dec 28; 9(1). PMID: 31878087    Free PMC article.
Review.
Biomarkers for immunotherapy for treatment of glioblastoma.
John P Lynes, Anthony K Nwankwo, +5 authors, Edjah K Nduom.
J Immunother Cancer, 2020 Jun 01; 8(1). PMID: 32474411    Free PMC article.
Review.
Myeloid Cells as Clinical Biomarkers for Immune Checkpoint Blockade.
Elisa Peranzoni, Vincenzo Ingangi, +2 authors, Ilaria Marigo.
Front Immunol, 2020 Aug 15; 11. PMID: 32793228    Free PMC article.
Review.
Nanobodies: Next Generation of Cancer Diagnostics and Therapeutics.
Emily Y Yang, Khalid Shah.
Front Oncol, 2020 Aug 15; 10. PMID: 32793488    Free PMC article.
Review.
TREM2 Modulation Remodels the Tumor Myeloid Landscape Enhancing Anti-PD-1 Immunotherapy.
Martina Molgora, Ekaterina Esaulova, +18 authors, Marco Colonna.
Cell, 2020 Aug 14; 182(4). PMID: 32783918    Free PMC article.
PD-L1 on dendritic cells attenuates T cell activation and regulates response to immune checkpoint blockade.
Qi Peng, Xiangyan Qiu, +8 authors, Haidong Tang.
Nat Commun, 2020 Sep 26; 11(1). PMID: 32973173    Free PMC article.
Targeting Tumor-Associated Macrophages to Increase the Efficacy of Immune Checkpoint Inhibitors: A Glimpse into Novel Therapeutic Approaches for Metastatic Melanoma.
Claudia Ceci, Maria Grazia Atzori, Pedro Miguel Lacal, Grazia Graziani.
Cancers (Basel), 2020 Nov 21; 12(11). PMID: 33212945    Free PMC article.
Review.
Advances in the In Vivo Molecular Imaging of Invasive Aspergillosis.
Matthias Gunzer, Christopher R Thornton, Nicolas Beziere.
J Fungi (Basel), 2020 Dec 10; 6(4). PMID: 33291706    Free PMC article.
Review.
Noninvasive Imaging of Cancer Immunotherapy.
Omar Abousaway, Taha Rakhshandehroo, +2 authors, Mohammad Rashidian.
Nanotheranostics, 2021 Jan 05; 5(1). PMID: 33391977    Free PMC article.
Review.
Rethinking immune checkpoint blockade: 'Beyond the T cell'.
Xiuting Liu, Graham D Hogg, David G DeNardo.
J Immunother Cancer, 2021 Jan 21; 9(1). PMID: 33468555    Free PMC article.
Review.
Cargo-free immunomodulatory nanoparticles combined with anti-PD-1 antibody for treating metastatic breast cancer.
Yining Zhang, Kevin R Hughes, +4 authors, Lonnie D Shea.
Biomaterials, 2021 Jan 19; 269. PMID: 33461057    Free PMC article.
ImmunoPET imaging of human CD8+ T cells with novel 68Ga-labeled nanobody companion diagnostic agents.
Haitao Zhao, Chao Wang, +8 authors, Jianjun Liu.
J Nanobiotechnology, 2021 Feb 11; 19(1). PMID: 33563286    Free PMC article.
Next Generation Imaging Techniques to Define Immune Topographies in Solid Tumors.
Violena Pietrobon, Alessandra Cesano, Francesco Marincola, Jakob Nikolas Kather.
Front Immunol, 2021 Feb 16; 11. PMID: 33584676    Free PMC article.
Review.
CXCL9-expressing tumor-associated macrophages: new players in the fight against cancer.
Paola Marie Marcovecchio, Graham Thomas, Shahram Salek-Ardakani.
J Immunother Cancer, 2021 Feb 28; 9(2). PMID: 33637602    Free PMC article.
Review.
The Future of Cancer Diagnosis, Treatment and Surveillance: A Systemic Review on Immunotherapy and Immuno-PET Radiotracers.
Virginia Liberini, Riccardo Laudicella, +5 authors, Désirée Deandreis.
Molecules, 2021 May 01; 26(8). PMID: 33920423    Free PMC article.
Systematic Review.
ImmunoPET of CD38 with a radiolabeled nanobody: promising for clinical translation.
Sixiang Shi, Shreya Goel, Xiaoli Lan, Weibo Cai.
Eur J Nucl Med Mol Imaging, 2021 May 05; 48(9). PMID: 33942140    Free PMC article.
Nanobodies for Medical Imaging: About Ready for Prime Time?
Léa Berland, Lauren Kim, +5 authors, Mohammad Rashidian.
Biomolecules, 2021 May 01; 11(5). PMID: 33925941    Free PMC article.
Review.
Nanobodies in cancer.
Elisha R Verhaar, Andrew W Woodham, Hidde L Ploegh.
Semin Immunol, 2020 Dec 05; 52. PMID: 33272897    Free PMC article.
Review.
Nanobodies as in vivo, non-invasive, imaging agents.
Thibault J Harmand, Ashraful Islam, Novalia Pishesha, Hidde L Ploegh.
RSC Chem Biol, 2021 Jul 03; 2(3). PMID: 34212147    Free PMC article.
Review.
Predictive Markers of Immunogenicity and Efficacy for Human Vaccines.
Matthieu Van Tilbeurgh, Katia Lemdani, +8 authors, Caroline Manet.
Vaccines (Basel), 2021 Jul 03; 9(6). PMID: 34205932    Free PMC article.
Review.
CPPs to the Test: Effects on Binding, Uptake and Biodistribution of a Tumor Targeting Nanobody.
Estel Collado Camps, Sanne A M van Lith, +4 authors, Roland Brock.
Pharmaceuticals (Basel), 2021 Jul 03; 14(7). PMID: 34201507    Free PMC article.
Positron emission tomography imaging with 89Zr-labeled anti-CD8 cys-diabody reveals CD8+ cell infiltration during oncolytic virus therapy in a glioma murine model.
Benjamin B Kasten, Hailey A Houson, +10 authors, Anna G Sorace.
Sci Rep, 2021 Jul 30; 11(1). PMID: 34321569    Free PMC article.
CD8+ T Cell Exhaustion in Cancer.
Joseph S Dolina, Natalija Van Braeckel-Budimir, Graham D Thomas, Shahram Salek-Ardakani.
Front Immunol, 2021 Aug 07; 12. PMID: 34354714    Free PMC article.
Review.
Converting an Anti-Mouse CD4 Monoclonal Antibody into an scFv Positron Emission Tomography Imaging Agent for Longitudinal Monitoring of CD4+ T Cells.
Ashraful Islam, Novalia Pishesha, +6 authors, Hidde L Ploegh.
J Immunol, 2021 Aug 20; 207(5). PMID: 34408009    Free PMC article.
JAML promotes CD8 and γδ T cell antitumor immunity and is a novel target for cancer immunotherapy.
Joseph M McGraw, Flavian Thelen, +4 authors, Deborah A Witherden.
J Exp Med, 2021 Aug 25; 218(10). PMID: 34427588    Free PMC article.
The future of microfluidics in immune checkpoint blockade.
Jonathan Briones, Wilfred Espulgar, +3 authors, Masato Saito.
Cancer Gene Ther, 2020 Oct 29; 28(9). PMID: 33110208
Review.
High-performance renal imaging with a radiolabeled, non-excretable chimeric fusion protein.
Dawei Jiang, Muhsin H Younis, Xiaoli Lan, Weibo Cai.
Theranostics, 2021 Sep 16; 11(18). PMID: 34522233    Free PMC article.
ImmunoPET: harnessing antibodies for imaging immune cells.
Anna M Wu, Neeta Pandit-Taskar.
Mol Imaging Biol, 2021 Sep 23; 24(2). PMID: 34550529
Review.
Granzyme B PET Imaging of Combined Chemotherapy and Immune Checkpoint Inhibitor Therapy in Colon Cancer.
Julian L Goggi, Siddesh V Hartimath, +14 authors, Edward G Robins.
Mol Imaging Biol, 2021 Mar 14; 23(5). PMID: 33713000    Free PMC article.
PET Imaging of Translocator Protein as a Marker of Malaria-Associated Lung Inflammation.
Julian L Goggi, Carla Claser, +10 authors, Laurent Renia.
Infect Immun, 2021 Jul 13; 89(10). PMID: 34251290    Free PMC article.
Radiolabeling Strategies of Nanobodies for Imaging Applications.
Jim Küppers, Stefan Kürpig, +2 authors, Susanne Lütje.
Diagnostics (Basel), 2021 Sep 29; 11(9). PMID: 34573872    Free PMC article.
Review.
Spatial deconvolution of HER2-positive breast cancer delineates tumor-associated cell type interactions.
Alma Andersson, Ludvig Larsson, +10 authors, Joakim Lundeberg.
Nat Commun, 2021 Oct 16; 12(1). PMID: 34650042    Free PMC article.
Immunostimulatory effects of targeted thorium-227 conjugates as single agent and in combination with anti-PD-L1 therapy.
Pascale Lejeune, Véronique Cruciani, +17 authors, Urs B Hagemann.
J Immunother Cancer, 2021 Oct 08; 9(10). PMID: 34615703    Free PMC article.
Conditional Deletion of Pdcd1 Identifies the Cell-Intrinsic Action of PD-1 on Functional CD8 T Cell Subsets for Antitumor Efficacy.
Sukanya Raghavan, Nataliya Tovbis-Shifrin, +10 authors, Rene de Waal Malefyt.
Front Immunol, 2021 Dec 17; 12. PMID: 34912335    Free PMC article.
Combinatorial immunotherapy induces tumor-infiltrating CD8+ T cells with distinct functional, migratory, and stem-like properties.
Natalija Van Braeckel-Budimir, Joseph Samuel Dolina, +14 authors, Shahram Salek-Ardakani.
J Immunother Cancer, 2021 Dec 15; 9(12). PMID: 34903555    Free PMC article.
What Happens to the Immune Microenvironment After PD-1 Inhibitor Therapy?
Qingyi Wang, Bin Xie, +4 authors, Wenxiang Wang.
Front Immunol, 2022 Jan 11; 12. PMID: 35003090    Free PMC article.
Review.
Diagnosis of Glioblastoma by Immuno-Positron Emission Tomography.
Eduardo Ruiz-López, Juan Calatayud-Pérez, +4 authors, Alberto J Schuhmacher.
Cancers (Basel), 2022 Jan 12; 14(1). PMID: 35008238    Free PMC article.
Review.
Granzyme B PET Imaging in Response to In Situ Vaccine Therapy Combined with αPD1 in a Murine Colon Cancer Model.
Siddesh V Hartimath, Boominathan Ramasamy, +6 authors, Julian L Goggi.
Pharmaceutics, 2022 Jan 22; 14(1). PMID: 35057046    Free PMC article.
Application of Noninvasive Imaging to Combined Immune Checkpoint Inhibitors for Breast Cancer: Facts and Future.
Zhongquan Cheng, Yang Du, +2 authors, Jie Tian.
Mol Imaging Biol, 2022 Feb 02; 24(2). PMID: 35102468
Review.
PET/CT Imaging of Activated Cancer-Associated Fibroblasts Predict Response to PD-1 Blockade in Gastric Cancer Patients.
Xiaoxiang Rong, Jinyu Lv, +10 authors, Chunlin Wang.
Front Oncol, 2022 Feb 15; 11. PMID: 35155199    Free PMC article.
Aspirin activates resolution pathways to reprogram T cell and macrophage responses in colitis-associated colorectal cancer.
Roberta De Matteis, Magdalena B Flak, +4 authors, Jesmond Dalli.
Sci Adv, 2022 Feb 03; 8(5). PMID: 35108049    Free PMC article.
Molecular Immune Targeted Imaging of Tumor Microenvironment.
Taha Rakhshandehroo, Bryan Ronain Smith, +2 authors, Neeta Pandit-Taskar.
Nanotheranostics, 2022 Mar 01; 6(3). PMID: 35223381    Free PMC article.
Review.
Establishing Imaging Biomarkers of Host Immune System Efficacy during Glioblastoma Therapy Response: Challenges, Obstacles and Future Perspectives.
Ana Paula Candiota, Carles Arús.
Metabolites, 2022 Mar 25; 12(3). PMID: 35323686    Free PMC article.
In vivo labeling reveals continuous trafficking of TCF-1+ T cells between tumor and lymphoid tissue.
Zhi Li, Zewen K Tuong, +16 authors, David R Withers.
J Exp Med, 2022 Apr 27; 219(6). PMID: 35472220    Free PMC article.